Ftse Mib
33.305,46
-1,34%
DAX
19.060,31
-0,60%
S&P 500
5.916,98
0,40%
NASDAQ
18.987,47
1,04%
Bitcoin
92.514,44
2,17%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Korro Bio Inc (KRRO) Korro Bio Inc (KRRO) Notizie

Korro Bio Inc

KRRO
46,63
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:01:41
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202415:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:00GLOBEKorro to Present at the Jefferies London Healthcare..
13/11/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEKorro Reports Third Quarter 2024 Financial Results and..
12/11/202414:28EDGAR2Form 144 - Report of proposed sale of securities
04/11/202413:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/11/202413:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/11/202413:30EDGAR2Form 8-K - Current report
04/11/202413:25GLOBEKorro Announces Regulatory Filing for Initiation of KRRO-110..
19/10/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202422:22EDGAR2Form 144 - Report of proposed sale of securities
16/10/202419:05EDGAR2Form 144 - Report of proposed sale of securities
30/9/202414:00GLOBEKorro Announces Oral and Poster Presentations at the 20th..
16/9/202414:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202414:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202414:05EDGAR2Form 8-K - Current report
16/9/202414:00GLOBEKorro Bio Announces Collaboration with Novo Nordisk to..
10/9/202414:00GLOBEKorro to Participate in Upcoming Investor Conferences
04/9/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202401:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202423:28EDGAR2Form 144 - Report of proposed sale of securities
29/8/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202401:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/8/202422:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202422:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202422:10EDGAR2Form 8-K - Current report
28/8/202414:00GLOBEKorro Announces Addition of Industry Veteran Katharine..
27/8/202414:00GLOBEKorro to Participate in Upcoming September Investor and..
13/8/202422:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:06EDGAR2Form 8-K - Current report
13/8/202422:01GLOBEKorro Reports Second Quarter 2024 Financial Results and..
01/7/202414:00GLOBEKorro Joins the Russell 2000®, Russell 3000®, and Russell..
17/6/202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/6/202422:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/6/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
05/6/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:01GLOBEKorro to Participate in Upcoming June Investor and..
23/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/5/202422:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/5/202420:30GLOBEKorro Presents Additional Preclinical Data for KRRO-110 at..
15/5/202402:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:34EDGAR2Form S-1 - General form for registration of securities under..
Apertura: 46,49 Min: 44,65 Max: 48,1899
Chiusura: 46,63

La tua Cronologia

NASDAQ
KRRO
Korro Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network